ArticleChemical science2026
X-Align: annotation-independent cross-platform alignment of untargeted metabolomics features.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Massive untargeted metabolomics datasets are rapidly accumulating, but cross-study and cross-platform reuse remain limited by poor comparability. This limitation is exacerbated by the low rate of confident structural annotation, which restricts structure-based alignment to only a small fraction of detected metabolic features. Here, X-Align is presented, which is an annotation-independent framework for cross-platform alignment of untargeted metabolomics features. Its core component, Align-ID, is a residual attention-based deep regression model that learns reference chromatographic behavior directly from MS/MS (tandem mass spectrometry) spectrum embeddings and maps heterogeneous spectra onto a common reference chromatographic scale without prior structural identification. Align-ID is trained on 804 150 high-resolution MS/MS spectra associated with reference retention values in the METLIN SMRT chromatographic system. X-Align achieved 99.6% accuracy at 52.3% coverage in the controlled benchmark and maintained high accuracy in independent cross-platform and external library validations. X-Align produces a cross-center feature repository containing 1402 aligned features and 60 688 MS/MS spectra from public plasma datasets and supports more consistent biological interpretation across independent experiments in a cross-center high-fat diet case study. This work establishes MS/MS-derived reference retention behavior as a practical basis for annotation-independent comparison and integration of cross-platform untargeted metabolomics data.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.